Completed NA INTERVENTIONAL 1-arm NCT05429658

Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMITNZ)

A Prospective, Single-arm, Interventional Clinical Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical MonoPoint Reperfusion System for Aspiration Embolectomy in Acute Ischemic Stroke Patients

Sponsor: Route 92 Medical, Inc.

Conditions Acute Ischemic Stroke

Interventions Thrombectomy

Updated 5 times since 2022 Last updated: Mar 26, 2024 Started: Sep 27, 2019 Primary completion: Nov 22, 2021 Completion: Feb 24, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Ischemic Stroke and is currently completed. Route 92 Medical, Inc. leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA
Jan 2024 — Apr 2024 [monthly]

Completed NA
Jul 2022 — Jan 2024 [monthly]

Completed NA

First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Route 92 Medical, Inc.

Data source: Route 92 Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Auckland, New Zealand
• Christchurch, New Zealand